| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 | 1,957 | 2,064 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 | 1,398 | 1,505 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 | 559 | 559 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % | 27 % | 26 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 | 403 | 400 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 | 84 | 93 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 |
Max Healthcare Institute
Max Healthcare Institute
1,103.10
+5.10
(0.46%)
There are 1 new updates from the company1 day ago
View
Key Fundamentals
Market Cap
1,06,751.60 Cr
EPS
11.07
PE Ratio
93.34
Dividend Yield
0.14 %
Industry
Healthcare Services 52 Week High
1,314.30
52 Week Low
936.25
PB Ratio
11.41
Debt to Equity
0.24
Sector
Hospitals Analyst Rating and Forecast
- By Refinitiv from20 analysts
Actual
Company News
View All News
Max Healthcare Reports 74% Profit Jump Driven by Outpatient and International Revenue Growth
6 hours ago
6 hours agoMax Healthcare Institute reported net profit of ₹491 crore for the September quarter, up 74.3% year-on-year, with revenue rising 25% to ₹2,135 crore driven by increased outpatient visits and international patient revenue. The healthcare provider expanded operations with new facilities while maintaining strong EBITDA margins at 26.9%, though net debt increased to ₹2,067 crore from ongoing expansion investments.
Max Healthcare Allots 2.16 Lakh Equity Shares Under Employee Stock Option Scheme9 hours ago
Max Healthcare Institute Limited's Nomination Remuneration Committee approved allotment of 2,16,084 equity shares with face value of ₹10 each to eligible employees under its Employee Stock Option Scheme 2022. The allotment increased the company's paid-up equity capital from ₹972.24 crore to ₹972.45 crore, with exercise prices of ₹350 and ₹700 per share for different tranches.
Max Healthcare Schedules Earnings Call for Q2 H1 FY26 Results on November 17, 20254 days ago
Max Healthcare Institute Limited has announced an earnings call for investors and analysts scheduled for November 17, 2025, at 11:30 AM IST. The call will discuss the company's financial results for the quarter and half-year ended September 30, 2025, which will be declared on November 14, 2025. The conference call will feature the senior management team and include a management discussion followed by a Q&A session. Max Healthcare operates 21 healthcare facilities with 5,200 beds, primarily in North India, including hospitals in Delhi NCR, Lucknow, Mumbai, Nagpur, Mohali, Bathinda, and Dehradun. The company also operates home care services under Max@Home and diagnostic services through MaxLabs.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,420.50 | #1 1,06,983.00 | 61.70 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 32.30 | |
1,103.10 | #2 1,06,751.60 | #8 93.34 | #3 7,184.10 | #1 28.65 | #2 1,076 | #2 30.34 | 37.61 | |
937.70 | 71,947.50 | 68.17 | 7,849.70 | 13.25 | 809 | #1 70.27 | 30.01 | |
1,753.50 | 36,317.00 | #1 45.61 | 5,575.00 | 12.29 | 790 | -2.38 | 45.38 | |
678.10 | 34,877.30 | 96.29 | 4,286.70 | 15.12 | 337 | 14.65 | 48.34 | |
1,174.90 | 32,303.20 | 56.27 | 3,771.40 | 12.59 | 481 | 21.10 | 31.53 | |
665.00 | 27,135.40 | 74.81 | 3,067.00 | 21.98 | 415 | -40.35 | 34.47 | |
1,341.50 | 13,768.40 | 52.75 | 1,566.90 | 17.46 | 244 | -4.30 | 41.48 | |
739.85 | 10,595.50 | 253.48 | 2,257.70 | 17.03 | 49 | 0.00 | 53.38 | |
1,464.10 | 9,820.50 | 48.26 | 1,290.20 | 17.77 | 194 | 11.00 | 37.65 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
28.65 %
Net Income Growth
1.73 %
Cash Flow Change
30.09 %
ROE
-8.82 %
ROCE
-11.54 %
EBITDA Margin (Avg.)
-6.72 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 851 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 2,915 | 1,125 | 1,000 | 1,943 | 1,706 | 1,593 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 553 | 901 |
| Investments | 143 | 0 | 0 | 0 | 1 | 2,182 | 1 | 1 | 1 | 2 | 3 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 913 | 1,981 | 2,020 | 2,810 | 2,661 | 2,809 |
| Total Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,010 | 777 | 757 | 1,046 | 1,249 | 1,814 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 411 | 2,129 | 2,149 | 1,647 | 2,343 | 4,020 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 2,553 | 5,639 | 6,283 | 7,410 | 8,408 | 9,381 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 2,016 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | -211 | 516 | -318 | 893 | -395 | -319 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -2,641 | 206 | -772 | -102 | -1,253 | -1,614 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 77 | 118 | 749 | 1,284 | 1,122 | 1,459 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 2,353 | 191 | -294 | -289 | -264 | -164 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % | 54.74 % | 54.76 % | 51.80 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % | 17.58 % | 17.42 % | 20.03 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % | 3.31 % | 3.42 % | 3.08 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % | 0.63 % | 0.66 % | 1.35 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 | 1,51,633 | 1,62,119 | 1,80,891 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.14 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2023 |  Dividend | ₹ 1.00 /share | 08 Sept 2023 | 519.90 | 602.65 |
| 27 Sept 2023 |  Annual General Meeting | NA | 27 Sept 2023 | 553.60 | 566.10 |
| 23 Aug 2024 | Dividend | ₹ 1.50 /share | 23 Aug 2024 | 835.15 | 869.30 |
| 20 Sept 2024 | Annual General Meeting | NA | 20 Sept 2024 | 882.75 | 984.55 |
| 05 Nov 2024 |  Quarterly Result Announcement | NA | 05 Nov 2024 | 994.50 | 1,036.60 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,082.95 | 1,025.90 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 1,159.90 | 1,187.10 |
| 04 Jul 2025 | Dividend | ₹ 1.50 /share | 04 Jul 2025 | 1,187.10 | 1,301.40 |
| 30 Jul 2025 | Annual General Meeting | NA | 30 Jul 2025 | 1,190.20 | 1,274.30 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 1,272.30 | 1,260.60 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 1,135.30 | 1,098.00 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 1,135.30 | 1,098.00 |
Announcements
Presentation On Earnings Update9 hours ago
9 hours agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release9 hours ago
9 hours agoBoard Meeting Outcome for Meeting Held On November 14 20259 hours ago
9 hours agoResults - Financial Results For The Quarter And Half Year Ended September 30 20259 hours ago
9 hours agoAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS13 hours ago
13 hours agoGrant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 202213 hours ago
13 hours agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
4 days agoBoard Meeting Intimation for Consideration And Approval Of Financial Results6 days ago
6 days agoApproval Of Scheme Of Amalgamation Between Crosslay Remedies Limited And Jaypee Healthcare Limited7 days ago
7 days agoDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20157 days ago
7 days agoDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 22, 2025
Oct 22, 2025Communication To Members - 100 Days Campaign - Saksham NiveshakOct 09, 2025
Oct 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Announcement under Regulation 30 (LODR)-Credit RatingOct 02, 2025
Oct 02, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Oct 01, 2025
Oct 01, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Audio Recording Of Earnings Call Held On August 14 2025Aug 14, 2025
Aug 14, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 14, 2025
Aug 14, 2025Agreement To Lease For Establishing A ~130 Bedded Built-To-Suit Hospital At Dehradun UttarakhandAug 13, 2025
Aug 13, 2025Presentation On Earnings UpdateAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2025
Aug 13, 2025Board Meeting Outcome for Meeting Held On August 13 2025Aug 13, 2025
Aug 13, 2025Results - Financial Results For Quarter Ended June 30 2025Aug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 12, 2025
Aug 12, 2025Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Aug 12, 2025
Aug 12, 2025Minutes Of 24Th Annual General MeetingAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Aug 06, 2025Board Meeting Intimation for Consideration And Approval Of Financial ResultsAug 06, 2025
Aug 06, 2025Transcript Of 24Th Annual General MeetingAug 05, 2025
Aug 05, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 30, 2025
Jul 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 30, 2025
Jul 30, 2025Summary Of Proceedings Of 24Th Annual General MeetingJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 15, 2025
Jul 15, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 11, 2025
Jul 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2025
Jul 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2025
Jul 04, 2025Reg. 34 (1) Annual Report.Jul 04, 2025
Jul 04, 2025Notice Of 24Th Annual General Meeting And Integrated Annual Report For The Financial Year 2024-25Jul 04, 2025
Jul 04, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2025
Jul 01, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 26, 2025
Jun 26, 2025Mutual Fund Holdings
HDFC Large Cap Fund Direct-Growth 
Axis Midcap Direct Plan-Growth 
Nippon India Pharma Fund Direct-Growth 
Mahindra Manulife Mid Cap Fund Direct - Growth 
HSBC Midcap Fund Direct-Growth 
Quant Large Cap Fund Direct - Growth 
Kotak Arbitrage Fund Direct-Growth 
Franklin India Mid Cap Fund Direct-Growth 
SBI Arbitrage Opportunities Fund Direct-Growth 
Edelweiss Mid Cap Direct Plan-Growth 
ITI Mid Cap Fund Direct - Growth 
Aditya Birla Sun Life Arbitrage Fund Direct-Growth 
Invesco India Large & Mid Cap Fund Direct-Growth 
UTI Multi Asset Allocation Fund Direct-Growth 
Tata Arbitrage Fund Direct - Growth 
ICICI Prudential Equity Arbitrage Direct-Growth 
Canara Robeco Large and Mid Cap Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 35.71
ATR(14)
Less Volatile 27.43
STOCH(9,6)
Oversold 15.26
STOCH RSI(14)
Oversold 6.23
MACD(12,26)
Bearish -8.61
ADX(14)
Weak Trend 24.50
UO(9)
Bearish 38.70
ROC(12)
Downtrend And Accelerating -7.45
WillR(14)
Oversold -83.48
About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
